In Vitro Toxicity Testing: Technologies and Global Markets

In Vitro Toxicity Testing: Technologies and Global Markets

Report Scope:

This report examines the current and future market potential of In Vitro Toxicity Testing Technologies. It offers a detailed analysis of the competitive environment, the regulatory scenario, technological advancements, drivers, restraints, opportunity and trends in market growth. This report covers market projections through 2026 and market rank for key market players. The report details the market shares of In Vitro Toxicity Testing Technologies segmented by toxicity endpoints and tests, tools/technology, components and end users.

This report segments the global market by geographic region: North America, Europe, Asia-Pacific and the Rest of the world. The North American region includes the U.S., Canada and Mexico, the European region (including Germany, U.K., France and the Rest of Europe), the Asia-Pacific region (including China, India, Japan and the Rest of Asia-Pacific). For market estimates, data is provided for the year 2019-2020 as the base year and forecast through year-end, 2026.

Report Includes:

- 132 data tables and 30 additional tables
- An updated review of the global markets for in vitro toxicity testing and technologies under development
- Analyses of the global market trends, with data from 2019 to 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Technology assessment of the key drivers, restraints and opportunities that will shape the market for in vitro toxicity testing over the next five years (2021 to 2026)
- Evaluation and forecast the overall market size, and corresponding market share analysis by toxicity endpoints and tests, tool/technology, component, end-user industry and geographic region
- Highlights of COVID-19 implications on the progress of this market
- Country specific data and market value analysis for the U.S., Canada, Mexico, Germany, U.K., France, Japan, China and India
- Review of key technology developments, latest market trends, and other influential factors such as validation and testing strategies for pharmaceuticals, cosmetics and chemicals
- Insight into recent industry structure, current competitive landscape, R&D activities, and regulatory and legislative issues currently focused on in vitro toxicology testing
- Descriptive company profiles of the leading market players, including Abbott Laboratories Inc., GE Healthcare, PerkinElmer Inc., Qiagen NV and Thermo Fisher Scientific Inc.

Companies Mentioned

ABBOTT LABORATORIES, INC.
ACEA BIOSCIENCES INC.
AGILENT TECHNOLOGIES INC.
ALBANY MOLECULAR RESEARCH INC.
APTUIT INC.
BIOGNOSYS AG
BIORELIANCE
BIOVIA
CELLULAR DYNAMICS INTERNATIONAL INC.
CHANTEST
CHARLES RIVER LABORATORIES
COVANCE INC.
CYPROTEX PLC
DRIK LLC
ENZO LIFE SCIENCES INC.
ESSEN BIOSCIENCE INC.
EUROFINS SCIENTIFIC SE
EVOTEC AG
GE HEALTHCARE
GENEDATA
GENTRONIX LTD.
HUREL CORP.
IMQUEST BIOSCIENCES INC.
IMSTAR SA
INSPHERO AG
KIYATEC INC.
LONZA GROUP LTD.
METABOLON INC.
MOLECULAR DEVICES LLC
PERKINELMER INC.
PROMEGA CORP.
QIAGEN NV
SGS-SA
STEMINA BIOMARKER DISCOVERY INC.
SYNVIVO, INC.
THERMO FISHER SCIENTIFIC INC.
VALA SCIENCES INC.
VISTAGEN THERAPEUTICS INC.
XENOMETRIX AG